Viktor E. Radzinsky’s research while affiliated with Peoples' Friendship University of Russia and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (32)


"Neutrality in everything," or "endocrine-metabolic nocturne" of the combined oral contraceptive based on E4/drospirenone: A review
  • Article
  • Full-text available

March 2025

·

21 Reads

GYNECOLOGY

Mekan R. Orazov

·

Viktor E. Radzinsky

·

One of the most controversial issues of modern gynecology is the study of the effect of combined oral contraceptives (COCs) on the endocrine-metabolic profile. Unfortunately, there are still hormonophobic prejudices in society about the adverse impact of COCs on body weight, carbohydrate metabolism, and lipid profile despite no evidence base for such judgments. Therefore, the purpose of the article is to analyze the effect of E4/drospirenone-based COCs on endocrine-metabolic parameters through the lens of evidence-based medicine.

Download

Obesity and metabolic dysfunction in pathogenesis of pelvic organ prolapse

January 2025

Pelvic organ prolapse (POP) has a considerable negative effect on the women’s quality of life. The rate of POP will grow due to population ageing (according to forecasts, by 46% by the year 2050). The global prevalence of obesity is increasing dramatically: according to the WHO forecasts, more than 50% of the Earth’s population (more than 4 billion people) will be overweight or obese by the year 2035. Obesity and dyslipidemia (elevated levels of triglycerides, low-density lipoprotein cholesterol; decreased levels of high-density lipoproteins) can trigger the development and progression of POP. However, this aspect of the POP pathogenesis is poorly understood. Aim: to expand the knowledge about the POP pathogenesis in patients with obesity and metabolic disorders. Methods. Analysis of the results of the studies published in the CochraneLibrary, PubMed, Science Direct, ELibrary digital libraries in 2010–2024 for the keywords “pelvic organ prolapse/пролапс тазовых органов”, “recurrence/рецидив”, “pathogenesis/патогенез”, “metabolic syndrome/метаболический синдром”, “abdominal obesity/абдоминальное ожирение”, “hypertriglyceridemia/гипертриглицеридемия”, “hypercholesterolemia/гиперхолестеринемия” was performed. Results. Coupled with the mechanical load caused by abdominal obesity, chronic systemic inflammation associated with metabolic syndrome, elevated levels of pro-inflammatory cytokines and activation of matrix metalloproteinases, as well as oxidative stress can result in weakening of the pelvic organ supportive structures, and microvascular dysfunction disturbes local hemodynamics, thereby contributing to the pelvic floor connective tissue remodeling processes. Conclusion. Qualitative studies involving large samples are necessary for better understanding of the pathogenetic mechanisms underlying the development of primary POP and POP recurrence, as well as for the development of the treatment approaches contributing to reducing the risk of progression. The management tactics for patients with POP associated with metabolic syndrome requires a multidisciplinary approach.


Obesity: proliferative risk and the possibility of overcoming it

January 2025

Obesity still remains a global and most urgent problem of the world’s public health system. Exponential growth of incidence all over the world has encouraged the World Health Organization (WHO) to declare that obesity is a global non-communicable pandemic of the 21st century. In the recent decades, a rapid increase in the prevalence of overweight and obesity that are inevitably associated with carcinogenic risk, including proliferative disorders (hyperplasia) and endometrial cancer, is reported globally. The today’s epidemiological data demonstrate that there is a strong correlation between obesity and endometrial hyperplasia (EH), which represent the associated clinical conditions based on many parameters (specifically, pathogenetic). The paper reports pathogenetic associations between obesity and EH, as well as modern strategies to overcome those based on the national and new international guidelines (2025).


Surgical treatment of recurrent pelvic organ prolapse: what is important to know?

January 2025

·

5 Reads

High rate of recurrence after surgical correction remains the key problem of the pelvic organ prolapse (POP) treatment, while the key objective is the search for the ways to improve surgical techniques. Various surgical approaches, including minimally invasive, involving the use of mesh implants or native tissues have been developed, but neither patients, nor surgeons are satisfied with the results. Aim: to analyze available scientific data on the efficacy and safety of surgical correction methods in terms of genital prolapse recurrence. Methods. Analysis of scientific papers published in the ELibrary, PubMed, CochraneLibrary, Science Direct databases in 2010–2024 for the keywords “pelvic organ prolapse/пролапс тазовых органов”, “rectocele/ректоцеле”, “cystocele/цистоцеле”, “apical prolapse/апикальный пролапс”, “recurrence/рецидив”, “surgical treatment/оперативное лечение” was performed. Results. To date, no perfect surgical approach to treatment of POP has been developed; no optimal surgical procedures for correction of primary and recurrent POP allowing one to avoid the disease progression have been proposed. A comprehensive personalized approach based on thorough assessment of the pelvic floor condition taking into account all the existing risk factors of primary POP or new disease progression factors in case of recurrence is the key to reducing the POP recurrence rate. Conclusion. Verification of fascial defects during preoperative and intraoperative periods is believed to be critical for improvement of the POP surgical treatment outcomes. Sufficient extent of surgical intervention, elimination of all fascial defects, optimal use of MESH technologies might improve anatomical and subjective operative results, as well as reduce the risk of recurrence. The use of synthetic implants in a number of studies has proven to be effective, regardless of the ongoing discussions about safety of such methods. It is necessary to continue the research on a large sample, since it will make it possible to improve the long-term treatment outcomes.


Safety and evidence base of a combined oral contraceptive based on estherol and drospirenone: a brief summary

September 2024

·

6 Reads

Family planning is a fundamental concept for building and development of society in the 21st century. The beliefs that developed over the last century and the priorities that changed resulted in the ecological and reproductive dissonance, the main consequences of which are the increasing age at first birth, decreasing total fertility rate, and increasing incidence of gynecological diseases. Hormonal contraception is one of the main family planning methods, which makes it possible to build up reserves for women’s reproductive health preservation and effectively control reproductive function. In turn, combined oral contraceptives (COCs) represent the most convenient method. Recently, an innovative estetrol/drospirenone-based COC, which, according to a number of studies, is among the most versatile and favorable in terms of extracontraceptive benefits, went on sale in the Russian Federation. In this regard, it is necessary to analyze the available data and create a concise summary of the proven advantages of this COC in the context of a number of characteristics.


Obesity and reproductive health: “nocturne” to modern comorbidity

September 2024

·

5 Reads

Modern trends of human lifestyle changes contribute to the unparalleled increase in the incidence of some occupational diseases. And, despite the development of modern technologies and such a pronounced leap in social development, obesity remains an unresolved issue of mankind. Today, obesity represents an overwhelming problem that needs to be solved immediately and covers many medical specialties, including gynecology. In this regard, the paper is aimed to consider epidemiological features of obesity as a global issue and report the key touchpoints with modern gynecology and key approaches to clinical management of patients of this cohort.


Hormone therapy for genitourinary syndrome of menopause: reality and prospects

September 2024

·

21 Reads

Genitourinary syndrome of menopause still represents one of the most pressing unresolved issues of modern gynecology. High prevalence and the data suggesting a marked decline in the quality of life in general and sexual life in particular in patients of this cohort demonstrate the need to develop effective clinical management programs. The review provided considers the key aspects of genitourinary syndrome of menopause as a medical and social problem, reports modern approaches to clinical management in the wake of new international guidelines.


The “iron curtain” of anti-aging: what is behind it?

September 2024

·

7 Reads

Currently, the conditions associated with iron deficiency are one of the most pressing unresolved issue of anti-aging medicine. Female patients of late reproductive age and perimenopausal/postmenopausal patients represent the most “vulnerable cohorts” in terms of iron deficiency realization. To date, both short-term and long-term effects of iron deficiency associated with adverse consequences for health and the quality of life have been proven. The review considers the key determinants of iron deficiency development in female patients of late reproductive age and perimenopausal/postmenopausal patients, as well as clinical management of such patients based on domestic and international guidelines.


Efficacy and safety of high-intensity electromagnetic stimulation in the prevention of recurrence of rectocele after surgical treatment

May 2024

·

3 Reads

Clinical review for general practice

Mekan R. Orazov

·

Viktor E. Radzinsky

·

Elena S. Silantieva

·

[...]

·

Anastasia E. Pavlova

The etiology of rectocele is diverse and can be caused by gynaecological and extragenital diseases, but the exact mechanisms of formation of anatomical, functional defects of the pelvic floor and methods of effective treatment from the position of prevention of recurrences remain quite contraversive. Complex postoperative rehabilitation after surgical treatment of rectocele is aimed at restoration of normal function of pelvic floor muscles and prevention of recurrences. It seems relevant to study the effectiveness of new methods of physiotherapy, such as high-intensity electromagnetic stimulation of the pelvic floor muscles, as a potential non-invasive, innovative option to reduce the recurrence rate of rectocele and related symptoms. This fact determined the focus of our study. Materials and мethods. 69 patients with rectocele and pelvic floor muscle insufficiency of hypokinetic phenotype (mean age 35.47±6.83 (95% CI 33.83–37.11) were included in the study. After surgical treatment, the patients of the study cohort were randomised into two groups: the main group (n=35) was treated with high-intensity electromagnetic stimulation of the pelvic floor muscles on the DR. ARNOLD device (DEKA M.E.L.A., Italy) to prevent recurrences, and the comparison group (n=34) was treated with cavity electrostimulation. Electromyography was used to objectively assess the state of pelvic floor muscles; accordingly, the quality of life and sexual function of the patients in the study cohort were analysed on the basis of specially adapted perineological questionnaires PFDI-20 and PFIQ-7. Results. Electromyography revealed a 1.4-fold increase in maximum and average contraction, increased endurance and normalisation of pelvic floor muscle tone in the study cohort (p<0.05). In addition, the patients of the main group, after high-intensity electromagnetic stimulation there was a persistent improvement in the quality of life and sexual function on the questionnaires PFDI-20 and PFIQ-7 after treatment and after 3 and 6 months, compared with baseline data and the comparison group (p<0.05). The results of the study showed that the use of high-intensity electromagnetic stimulation of the pelvic floor muscles on the DR. ARNOLD device (DEKA M.E.L.A., Italy) significantly reduces the frequency of recurrence of rectocele by 4.1 times in comparison with the cavity electrostimulation. Conclusion. The use of high-intensity electromagnetic stimulation (DR. ARNOLD, DEKA, Italy) is a highly effective and safe method of treatment of pelvic floor muscle insufficiency with hypokinetic phenotype in female patients after surgical treatment of rectocele, which contributes to the reduction of clinical symptoms, improvement of functional state of pelvic floor muscles, improvement of quality of life and sexual function, as well as reduction of recurrence rate.


"Ringed by fate". Carcinogenic risks in patients with polycystic ovary syndrome

March 2024

·

2 Reads

Clinical review for general practice

Polycystic ovary syndrome is a proven risk factor for both endometrial hyperplasia and cancer. The article reflects the current paradigm of etiology, pathogenesis and management of patients with endometrial hyperplasia on the background of polycystic ovary syndrome, according to the data of domestic and foreign literature.


Citations (6)


... На рентгенограмме выпячивание превышает 4 см. Эта степень ректоцеле часто сочетается с выпадением передней стенки влагалища, цистоцеле, опущением и выпадением матки [27]. ...

Reference:

Pelvic organ prolapse: modern diagnostic and treatment strategies
Pathogenesis of vaginal prolapse with the formation of rectocele: a review

GYNECOLOGY

... Current literature explores different techniques and timing of labor induction, including the specific circumstances under which it is performed, along with the maternal care provided during the process. [9]. The pharmacological methods mainly comprise intravaginal or cervical prostaglandins, oxytocin, amniotomy, oxytocin combined with amniotomy, oral misoprostol, vaginal misoprostol, and buccal or sublingual misoprostol. ...

Mechanical methods for induction of labor
  • Citing Article
  • October 2021

European Journal of Obstetrics & Gynecology and Reproductive Biology

... Так, у пациенток первых 2 групп показатели болевого синдрома уже через 3 мес лечения снизились в 1,6 раза, а через 6 мес достигнуто полное купирование боли. У пациенток 3-й группы через 3 мес терапии интенсивность болевого синдрома снизилась в 2 раза, а через 6 мес -в 3 раза по сравнению с исходными показателями (p<0,001) [6]. ...

The effectiveness of therapy for endometriosis-associated pelvic pain resistant to surgical treatment

GYNECOLOGY

... Combined oral contraceptives work by preventing ovulation and reducing the growth of the endometrial tissue, which in turn decreases menstrual blood volume, prostaglandin secretion, and uterine cramps (8). Progestins can be used to treat dysmenorrhea, such as medroxyprogesterone acetate (MPA) 5 mg or dydrogesterone 2×10 mg, taken from day 5 to 25 of the menstrual cycle (9). ...

Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study

Fertility and Sterility

... Endometriosis is a disease that not only causes pelvic pain due to chronic inflammation and decreases quality of life but also negatively impacts fertility. It significantly lowers the chance of spontaneous conception as well as conception after assisted reproductive treatment (ART) [7]. Mechanisms that affect fertility in patients with endometriosis are multifactorial: possible pathophysiological factors leading to infertility are inflammatory changes of the peritoneal fluid, reduced functional ovarian tissue, and endometrial changes [8]. ...

Obstetrical complications and outcome in patients with endometriosis

... Succinate (succinic acid / amber acid / butanedioic acid) has shown high efficacy at reversing key menopausal symptoms in two randomised, double-blind, placebo-controlled clinical trials [143] [144] . In the first trial, the daily dose used was 10.54-11.4 ...

Succinate-Based Dietary Supplement for Menopausal Symptoms: A Pooled Analysis of Two Identical Randomized, Double-Blind, Placebo-Controlled Clinical Trials